ClinicalTrials.gov
public full text
Public Domain
Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer
Randomized non-comparative phase II trial to assess the preliminary signs of antitumor activity of darolutamide plus radiation therapy in patients with unfavorable intermediate risk prostate cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer#826354
- Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation#906377
- Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer#1151430
- Study of ORIC-101 in Combination With Enzalutamide#896253
- Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer#830109
Record · ID 1151437
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive